R&D STATUS

  • Technologies
  • R&D STATUS

셀라피바이오 연구개발 현황입니다.

관리자 2023.11.22 10:27 Inquiry 289
  • 1. Development of multi-functional ester oil mass production technology for cosmetics using eco-friendly enzyme process, KRW 110, 000, 2020.04~2022.03, KRW 110, 000, Korean MFDS

  • 2. Development of technology for the production of recombinant antiviral drugs (3D8) using 2 yeast, 2020.02~200.08, KRW 55,000,000, NobleGen Co., Ltd

  • 3. Development of Recombinant Production and Enclosure Technology for 3 Functional Cosmetics, 2019.07~2019.12. KRW 50,000,000, KRIBB

  • 4. Development of recombinant scFv-HSA production technology using 4 yeast, 2019.02-2019.07, KRW 55,000,000, INTOCELL Co., Ltd

  • 5. Functional Cosmetics Composite Material Levan-EGF Nanoparticle Manufacturing Technology Development, 2018.12~2019.11, 115,000 won, Korea SMEs and Startups Agency

  • 6. Research on the High Production of Recombinant Protein Using 6 Yeast TFP Technology, 2018.11~2010.06, KRW 88,000,000, CJ Cheiljedang Co., Ltd
Next | No next article.
Prev | No previous article.